Peptide Eye Cream Market 2026: $2.8B Industry Driven by 12% CAGR, Clinical Efficacy Data & Ingredient Innovation
Abstract: The peptide eye cream market is projected to reach $2.8 billion by 2026, driven by a 12% CAGR. Clinical efficacy data validates ingredient innovation, with copper and matrixyl peptides leading in anti-aging benefits. Key brands (e.g., Olay, SkinCeuticals) compete via stability vs. penetration. Product parameters (concentration, pH) and certifications (GMP, FDA) dictate quality. Sourcing requires auditing factory GMP compliance and cold-chain logistics for stability. Industry trends favor multi-target formulations, while niche brands leverage clinical trials for EEAT authority.